Japanese Biotech Chugai Grants Exclusive VEGF-D Global License To Circadian Subsidiary Vegenics
This article was originally published in PharmAsia News
Executive Summary
Australian Circadian Technologies announced Jan. 13 that Chugai Pharmaceutical Co. has granted an exclusive, global license to its VEGF-D intellectual property to Circadian subsidiary Vegenics